Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 5/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 2/20 | 0.40 |
| ▸ | PPARA | Q07869 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13270945 | 0.91 | GPR88 (0.43) | ADORA2AADORA1ADORA3ALOX15TSHR | |
| SCHEMBL17407653 | 0.88 | ADORA3 (0.42) | MAPTADORA2AADORA1ADORA3ALOX15 | |
| SCHEMBL31499114 | 0.85 | RXRA (0.49) | MAPTADORA2AADORA1ADORA3ALOX15 | |
| SCHEMBL7957044 | 0.84 | PPARG (0.43) | MAPTADORA2AADORA1ADORA3ALOX15 | |
| SCHEMBL8038910 | 0.84 | PPARG (0.47) | ADORA2AADORA1ADORA3ALOX15TSHR | |
| SCHEMBL19421209 | 0.82 | PTPN11 (0.41) | MAPTADORA1ADORA3NPC1RAB9A | |
| SCHEMBL9635566 | 0.82 | MAPT (0.48) | MAPTADORA2AADORA1ADORA3ALOX15 | |
| SCHEMBL22216822 | 0.82 | CNR2 (0.39) | MAPTADORA2AADORA1ADORA3ALOX15 | |
| SCHEMBL13474410 | 0.81 | CYP1A2 (0.62) | MAPTADORA2AADORA1ADORA3ALOX15 | |
| SCHEMBL31260210 | 0.81 | CYP1A2 (0.62) | MAPTADORA2AADORA1ADORA3ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8585782-B2 | Use of specific bis(biphenyl)triazine derivatives and mixtures thereof as UV absorbers | BASF SE (DE) | 2013-11-19 | — | — | US | disclosed |
| US-8585782-B2 | Use of specific bis(biphenyl)triazine derivatives and mixtures thereof as UV absorbers | BASF SE (DE) | 2013-11-19 | — | — | US | disclosed |
| US-20130164231-A1 | Use of specific bis(biphenyl)triazine derivatives and mixtures thereof as UV absorbers | BASF SE (DE) | 2013-06-27 | — | — | US | disclosed |
| US-20130164231-A1 | Use of specific bis(biphenyl)triazine derivatives and mixtures thereof as UV absorbers | BASF SE (DE) | 2013-06-27 | — | — | US | disclosed |
| WO-2012034932-A1 | USE OF SPECIFIC BIS(BIPHENYL)TRIAZINE DERIVATIVES AND MIXTURES THEREOF AS UV ABSORBERS | BASF SE (DE) | 2012-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130164231-A1 | Use of specific bis(biphenyl)triazine derivatives and mixtures thereof as UV absorbers | NR1H2, CBR3, NR1H3 | MAPT 4821/4885ADORA2A 876/4885ADORA1 1852/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.